Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurora Deutschland
Leuna, Saxony-Anhalt, Germany
- Ownership
- Private
- Development stage
- Other
01
Overview
Aurora Deutschland, part of Aurora Cannabis Inc., is one of only three companies licensed to cultivate medical cannabis in Germany. It launched its first German-grown product under the IndiMed brand for the expanding German patient population in January 2025, using EU-GMP certified facilities and best practices for cultivation and quality control. Products are cultivated and manufactured for pharmaceutical use and distributed via regulated pharmacy supply chains.
- Therapeutic areas
- OtherNeurology
- Modalities
- BiologicSmall molecule
- Industry
- Biotech
02
Partnerships
Bundesverband pharmazeutischer Cannabinoidunternehmen e. V.Verband der Cannabis versorgenden Apotheken e. V.
Beyond the preview
Go deeper on Aurora Deutschland.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aurora Deutschland.